The epidemiology and impact of migraine

Current Neurology and Neuroscience Reports

Volumn 4, Issue 2, 2004, Pages 98-104

  Bigal, Marcelo E ^a   Lipton, Richard B ^b   Stewart, Walter F ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; METOCLOPRAMIDE; NON PRESCRIPTION DRUG; PLACEBO; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN;

AGE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONSULTATION; DIAGNOSTIC TEST; ETHNOLOGY; FAMILY HEALTH; GEOGRAPHY; HEADACHE; HEALTH CARE DELIVERY; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MIGRAINE; PHYSICAL DISABILITY; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SOCIAL ASPECT; SOCIAL STATUS; STANDARDIZATION; TREATMENT PLANNING; UNITED STATES; COST OF ILLNESS; ETHNIC GROUP; PSYCHOLOGICAL ASPECT; SOCIAL CLASS;

AGE FACTORS; COST OF ILLNESS; ETHNIC GROUPS; HUMANS; MIGRAINE DISORDERS; SEX FACTORS; SOCIAL CLASS;

EID: 1842538890     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0022-8     Document Type: Review

References (49)

1. Linet MS, Celentano DD, Stewart WF: Headache characteristics associated with physician consultation: a population-based survey. Am J Prev Med 1991, 7:40-46.
2. Pascual J, Combarros O, Leno C, et al.: Distribution of headache by diagnosis as the reason for neurologic consultation. Med Clin 1995, 104:161-164.
3. Scher AI, Stewart WF, Lipton RB: Migraine and headache: a meta-analytic approach. In Epidemiology of Pain. Edited by Crombie IK. Seattle, WA: IASP Press; 1999:159-170.
4. Rasmussen BK: Epidemiology of headache. Cephalalgia 1995, 15:45-68.
5. Lipton RB, Amatniek JC, Ferrari MD, et al.: Migraine: identifying and removing barriers to care. Neurology 1994, 44(suppl 6):56-62.
6. Headache classification committee of the international Headache Society: The International Classification of Headache Disorders. Cephalalgia 2004, 24(suppl 1);1-160.
7. Lipton RB, Stewart WF, Simon D: Medical consultation for migraine: results from the American Migraine Study. Headache 1998, 38:91-96.
8. Lipton RB, Diamond S, Reed M, et al.: Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001, 41:638-645.
9. Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657.
10. Waters WE: Headache (Series in Clinical Epidemiology). Littleton, MA: PSG Co; 1986.
11. Headache classification committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1-96.
12. Stewart WF, Linet MS, Celentano DD, et al.: Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1993, 34:1111-1120.
13. Breslau N, Davis GC, Schultz LR, Peterson EL: Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache 1994, 34:387-393.
14. Stang PE, Yanagihara T, Swanson JW, et al.: Incidence of migraine headaches: a population-based study in Olmsted County, Minnesota. Neurology 1992, 42:1657-1662.
15. Lipton RB, Stewart WF, Celentano DD, Reed ML: Undiagnosed migraine: a comparison of symptom-based and self-reported physician diagnosis. Arch Intern Med 1992, 152:1273-1278.
16. Lyngberg A, Jensen R, Rasmussen BK, Jorgensen T: Incidence of migraine in a Danish population-based follow-up study [abstract]. Cephalalgia 2003, 23:596.
17. Stewart WF, Simon D, Shechter A, Lipton RB: Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol 1995, 48:269-280.
18. Henry P, Michel P, Brochet B, et al.: A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992, 12:229-237.
19. Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM Study. Neurology 1999, 53:537-542.
20. Steiner T, Scher A, Stewart W, et al.: The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003, 23:519-527.
21. Sillanpaa M: Prevalence of migraine and other headache in Finnish children starting school. Headache 1976, 15:288-290.
22. Amayo EO, Jowi JO, Njeru EK: Headache associated disability in medical students at the Kenyatta National Hospital, Nairobi. East Afr Med J 2002, 79:519-523.
23. Orji GI, Iloeje SO: Childhood migraine in Nigeria - I: a community-based study. West Afr J Med 1997, 16:208-217.
24. Matuja WB, Mteza IB, Rwiza HT: Headache in a nonclinical population in Dar es Salaam, Tanzania. A community-based study. Headache 1995, 35:273-276.
25. Bille B: Migraine in school children. Acta Paediatr Scand 1962, 51(suppl 136):1-151.
26. Bille B: Migraine in children: prevalence, clinical features, and a 30-year follow-up. In Migraine and Other Headaches. Edited by Ferrari MD, Lataste X. New Jersey: Parthenon; 1989.
27. Sillanpaa M: Prevalence of migraine and other headache in Finnish children starting school. Headache 1976, 15:288-290.
28. Sillanpaa M: Prevalence of headache in prepuberty. Headache 1983, 23:10-14.
29. Silberstein SD, Merriam GR: Sex hormones and headache. In Blue Books of Practical Neurology: Headache. Edited by Goadsby P, Silberstein SD. Boston: Butterworth Heinemann; 1997:143-176.
30. Waters WE: Migraine: intelligence, social class, and familial prevalence. BMJ 1971, 2:77-81.
31. Stang PE, Sternfeld B, Sidney S: Migraine headache in a prepaid health plan: ascertainment, demographics, physiological and behavioral factors. Headache 1996, 36:69-76.
32. Stang PE, Osterhaus JT: Impact of migraine in the United States: data from the National Health Interview Survey. Headache 1993, 33:29-35.
33. Feinstein AR: The pretherapeutic classification of comorbidity in chronic disease. J Chronic Dis 1970, 23:455-468.
34. Lipton RB, Silberstein SD: Why study the comorbidity of migraine. Neurology 1994, 44:4-5.
35. Hu XH, Markson LE, Lipton RB, et al.: Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999, 159:813-818.
36. Lipton RB, Bigal ME, Kolodner K, et al.: The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003, 23:429-440.
37. Osterhaus JT, Gutterman DL, Plachetka JR: Health care resources and lost labor costs of migraine headaches in the United States. Pharmacoeconomics 1992, 2:67-76.
38. Holmes WF, MacGregor A, Dodick D: Migraine-related disability: impact and implications for sufferers' lives and clinical issues. Neurology 2001, 56(suppl 1):S13-S19.
39. Celentano DD, Stewart WF, Lipton RB, Reed ML: Medication use and disability among migraineurs: a national probability sample. Headache 1992, 32:223-228.
40. Fry J: Profiles of Disease. Edinburgh: Livingstone; 1996.
41. Consumer Healthcare Products Association: OTC Sales Statistics: 1995-1999. New York: AC Neilsen; April, 2000.
42. Rains JC, Penzien DB, Lipchik GL, et al.: Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia 2001, 21:584-595.
43. Russell MB, Olesen J: Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study. Cephalalgia 1996, 16:431-435.
44. Lipton RB, Stewart WF, von Korff M: Burden of migraine: societal costs and therapeutic opportunities. Neurology 1997,48(suppl 3):4-9.
45. Cady RC, Ryan R, Jhingran P, et al.: Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 1998, 158:1013-1018.
46. Dahlof C, Bouchard J, Cortelli P, et al.: A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. Pharmacoeconomics 1997, 11(suppl 1):24-34.
47. Santanello NC, Polis AB, Hartmaier SL, et al.: Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Cephalalgia 1997, 17:867-872.
48. Lipton RB, Dodick D, Sadovsky R, et al.: A self-administered screener for migraine in primary care: the ID Migraine(TM) validation study. Neurology 2003, 61:375-382.
49. Matchar DB, Young WB, Rosenerg J, et al.: Multispecialty consensus on diagnosis and treatment of headache: pharmacological management of acute attacks. Neurology 2000, 54. http://www.aan.com/public/practiceguidelines/03.pdf.